These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors. Ali N, Moiz B, Moatter T, Ahmed S, Adil SN, Khurshid M. Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507 [Abstract] [Full Text] [Related]
44. [Diagnosis and its problem for HCV hepatitis]. Sekiya C. Hokkaido Igaku Zasshi; 1993 Jul; 68(4):456-60. PubMed ID: 7687972 [No Abstract] [Full Text] [Related]
45. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS. N Engl J Med; 1992 Sep 24; 327(13):910-5. PubMed ID: 1325035 [Abstract] [Full Text] [Related]
46. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. Tan D, Matsumoto A, Conry-Cantilena C, Melpolder JC, Shih JW, Leuther M, Hess G, Gibble JW, Ness PM, Alter HJ. J Infect Dis; 1999 May 24; 179(5):1055-61. PubMed ID: 10191204 [Abstract] [Full Text] [Related]
47. Reproducibility of hepatitis C virus antibody detection with various confirmatory assays. Allain JP, Hewitt PE, Barbara JA, Dow BC, Follett EA, Davidson F. Transfusion; 1997 Sep 24; 37(9):989-91. PubMed ID: 9308654 [No Abstract] [Full Text] [Related]
48. Hepatitis C virus transmission in people who inject drugs: swabs may not be the main culprit. Maher L, Wand H. J Infect Dis; 2012 Jun 15; 205(12):1892; author reply 1892-3. PubMed ID: 22535997 [No Abstract] [Full Text] [Related]
49. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency. Múñoz FJ, de la Calle A, Giménez MJ, González J, Conde J. Allergol Immunopathol (Madr); 1995 Jun 15; 23(6):263-6. PubMed ID: 8579003 [Abstract] [Full Text] [Related]
50. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)]. Massenet D, Djime O. Bull Soc Pathol Exot; 1993 Jun 15; 86(4):235. PubMed ID: 7507370 [No Abstract] [Full Text] [Related]
51. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT, Wang TH, Sheu JC, Tsai SJ, Hsieh YS, Lin DT, Wang CY, Chen DS. Arch Pathol Lab Med; 1993 Feb 15; 117(2):152-6. PubMed ID: 8381269 [Abstract] [Full Text] [Related]
52. [Reduction of the proportion of anti-HCV-positive donations]. Quiles FJ, Sanz A, Cabanillas A, Sáenz P, Sánchez GM, Díaz F. Sangre (Barc); 1992 Apr 15; 37(2):153-4. PubMed ID: 1320294 [No Abstract] [Full Text] [Related]
53. Hepatitis C viraemia is spread by dialysis--the need for an isolation policy. al-Khader AA, al-Sulaiman MH, Saeed AA, al-Rasheed AM, Rankin D, McOmish F. Nephron; 1994 Apr 15; 68(4):514. PubMed ID: 7532795 [No Abstract] [Full Text] [Related]
54. From the Centers for Disease Control and Prevention. Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002. JAMA; 2003 Jun 25; 289(24):3235-6. PubMed ID: 12824200 [No Abstract] [Full Text] [Related]
57. Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease. Papatheodoridis GV, Delladetsima I, Koutelou M, Katsoulidou A, Hatzakis A, Tassopoulos NC. J Hepatol; 1994 Jun 25; 20(6):843. PubMed ID: 7523484 [No Abstract] [Full Text] [Related]